Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ezgi Şaman"'
Autor:
Michal Kluknavsky, Andrea Micurova, Martina Cebova, Ezgi Şaman, Sona Cacanyiova, Iveta Bernatova
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2385 (2022)
Reduced angiotensin 1–7 bioavailability due to inhibition of angiotensin-converting enzyme 2 (ACE2) may contribute to increased mortality in hypertensive individuals during COVID-19. However, effects of ACE2 inhibitor MLN-4760 in brain functions re
Externí odkaz:
https://doaj.org/article/58faea74ffa74fa098f819ce774bc573
Autor:
Ezgi Şaman, Martina Cebova, Andrej Barta, Martina Koneracka, Vlasta Zavisova, Anita Eckstein-Andicsova, Martin Danko, Jaroslav Mosnacek, Olga Pechanova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 276 (2022)
In addition to their LDL-cholesterol-lowering effect, statins have pleiotropic beneficial effects on the cardiovascular system. However, long-term treatment with statins may be associated with serious side effects. With the aim to make statin therapy
Externí odkaz:
https://doaj.org/article/5941626aaca7491b97d7bedd23157901
Autor:
Ezgi Şaman, Olga Pechanova
Publikováno v:
Biomedicines. 10:1090
Dyslipidemia is characterized by a diminished lipid profile, including increased level of total cholesterol and low-density lipoprotein cholesterol (LDL-c) and reduced level of high-density lipoprotein cholesterol (HDL-c). Lipid-lowering agents repre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437835a0e93e925f1acee53c895e5ef0
https://doi.org/10.3390/biomedicines10051090
https://doi.org/10.3390/biomedicines10051090